GlucoTrack Drops 24% Despite Successful First-in-Human Study Of CGM
GlucoTrack, Inc. (GCTK) is down by 24.56 percent during Tuesday trading despite announcing the successful completion of a ...
Hosted on MSN24d
DXCM's Preliminary Results Show Strong Growth: How to Play the Stock?
DexCom Inc. DXCM is off to a strong start in 2025, with its stock rallying 5.7% following the release of its preliminary results for the fourth quarter and fiscal 2024 on Jan. 13, 2025. The company’s ...
Seeking Alpha17d
Trinity Biotech climbs after data for glucose monitoring device
Based on data from 30 diabetic patients, Trinity (NASDAQ:TRIB) said its CGM device outperformed earlier Waveform CGM sensors, indicating a 25%–30% improvement in the mean absolute relative ...
GlucoTrack announces completion of first in human clinical study of CGM
Glucotrack (GCTK) announced the successful completion of its first in human clinical study, marking a significant milestone in continuous ...